Over 80% of Revenue in Hysteroscopy Systems Market to Come from Top 5 Players
The hysteroscopy systems market study by Fact.MR offers compelling insights into drivers and restraints impacting the growth through 2031. The survey offers hysteroscopy systems demand outlook and studies opportunities existing in key segments, including product and modality. It also highlights key strategies adopted by market players to increase hysteroscopy systems sales.
Fact.MR – A Market Research and Competitive Intelligence Provider: As per the insights by Fact.MR, the global hysteroscopy systems market is poised to expand at a CAGR of 5% over the forecast period 2019-2029.
The rising incidence of gynecological disorders such as polycystic ovary disease (PCOD) and uterine fibroids are propelling sales of hysteroscopy systems. As per a report, it is estimated that nearly 80% of women are affected by uterine fibroids during their lifetime.
According to the study, a gradual shift in reimbursement policies has encouraged hysteroscopy integration office-based set-ups, presenting a positive demand outlook. As per a report by National Payment Amounts, consumer spending on hysteroscopy procedures performed in the office has grown threefold, accounting for an average of US$ 1,382.1 in 2017 as compared to US$ 409.6 in 2016.
Want to publish your own articles on DistilINFO Publications?
Send us an email, we will get in touch with you.
Besides these, awareness campaigns such as “My hysteroscope is my Stethoscope” are pushing gynecologists to use hysteroscopy as a diagnostic tool.
Request a report sample to gain comprehensive insights at
Regionally, North America will emerge as a lucrative market owing to a growing preference for hysteroscopy procedures over traditional methods. Also, growth prospects are likely to remain positive in Europe due to stringent regulations implemented to encourage the replacement of traditional methods with hysteroscopy in doctor’s offices.
For instance, in 2018, The U.S. Food and Drug Administration (FDA) ordered restrictions on sales and distribution of the Essure device to ensure all women using permanent contraception devices are provided with accurate risk information to make informed decisions.
“Leading market players are leveraging advanced technology integration and innovations to offer a highly precise and specific based diagnosis. This, in turn, is bolstering growth prospects for hysteroscopy systems,” says a Fact.MR analyst.
Source: Biospace